Covidien, Dublin, Ireland, announced last week that it has reached a “definitive agreement” to acquire Newport Medical Instruments Inc. Covidien will acquire all of the outstanding capital stock of Newport Medical, which is privately owned and based in Costa Mesa, Calif, for approximately $108 million.

The acquisition is expected to be completed in the second quarter of 2012 and will expand Covidien’s current portfolio of respiratory care devices into ventilation products. Once the transaction is complete, Covidien will report the Newport Medical business as part of its Airway & Ventilation product line in the Medical Devices segment.

Source: Covidien